Claims
- 1. A mixture comprising an isolated mammalian netrin and an isolated mammalian netrin receptor selected from the group consisting of "Deleted in Colorectal Carcinoma" (DCC) and neogenin.
- 2. A mixture according to claim 1, wherein said receptor is "Deleted in Colorectal Carcinoma" (DCC).
- 3. A mixture according to claim 1, wherein said receptor is neogenin.
- 4. A mixture according to claim 1, wherein said netrin is a human netrin and said receptor is "Deleted in Colorectal Carcinoma" (DCC).
- 5. A mixture according to claim 1, wherein said netrin is a human netrin and said receptor is neogenin.
- 6. A mixture according to claim 1, wherein said netrin is a human netrin.
RELATED APPLICATION
This application is a division of Ser. No. 08/551,874 filed Oct. 16, 1996, issued as U.S. Pat. No. 5,747,262 on May 5, 1998.
Government Interests
The research carried out in the subject application was supported in part by grants from the National Institutes of Health. The government may have rights in any patent issuing on this application.
Non-Patent Literature Citations (2)
Entry |
Serafini et al., Cell, vol. 78, pp. 409-424, 1994. |
Vielmetter et al., J. Cell Bio., vol. 127, pp. 2009-2020, 1994. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
551874 |
Oct 1995 |
|